Iwaki Y, Terasaki P I, Park M S, Heintz R, Silberman H, Berne T
Transplant Proc. 1979 Mar;11(1):944-9.
Six serial dilutions of 51 sera from pretransplant patients were reacted against T and B lymphocytes at 5 degrees C and 37 degrees C. By the use of defined panels of T and B lymphocytes it could be shown that 10% of the 51 positive sera contained T-warm antibodies against HLA-A, -B, and -C specificities. There were 28% of the sera that had antibodies against non-HLA antigens reactive to B lymphocytes in the cold. Other sera contained mixtures of HLA and non-HLA antibodies. By dilution analysis of the sera, the mixtures could be detected and the HLA specificities identified. This ability to distinguish between HLA and non-HLA antibodies should be important in classifying pretransplant patients into high- and low-risk patients. Prior evidence that we have presented suggests that the non-HLA antibodies may be enhancing antibodies.
对51份移植前患者血清进行6次连续稀释,分别在5℃和37℃下与T淋巴细胞和B淋巴细胞反应。通过使用特定的T淋巴细胞和B淋巴细胞组合,可以发现51份阳性血清中有10%含有针对HLA - A、- B和- C特异性的T温抗体。有28%的血清含有在低温下对B淋巴细胞有反应的非HLA抗原抗体。其他血清则含有HLA和非HLA抗体的混合物。通过对血清进行稀释分析,可以检测到这些混合物并鉴定出HLA特异性。这种区分HLA和非HLA抗体的能力对于将移植前患者分为高风险和低风险患者应该很重要。我们之前提供的证据表明,非HLA抗体可能是增强抗体。